OpenAlex
PricingAboutJobs
Log inGet started
Work

Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer

HTML PDF

Year: 2013
Type: article
Source: Annals of Oncology
DOI: 10.1093/annonc/mdt074
Authors: S.K. Sandhu, A. Omlin, L. Hylands, S. Miranda, L.J. Barber, R. Riisnaes, A.H. Reid, G. Attard, L. Chen, I. Kozarewa, H. Gevensleben, J. Campbell, K. Fenwick, I. Assiotis, D. Olmos, T.A. Yap, P. Fong, N. Tunariu, D. Koh, L.R. Molife, S. Kaye, C.J. Lord, A. Ashworth, J. de Bono
Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research
Language: English

Topic: PARP inhibition in cancer therapy
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: bronze

Funders: National Cancer Research Institute, Cancer Research UK, National Institute for Health and Care Research
Awards: G2368474871, G2519382346, G4874885190, G4968764162, G8801512839
OpenAlex ID: W2168518457
FWCI: 5.173
Cites: 5
Cited by: 69
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms